St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

by Ysios Capital

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Sherpa Capital apuesta por el sector de ...

by Sherpa Capital

Sherpa Capital, firma de capital privado especializada en inversiones ...

Photos Stream